Metraipolis › archive › dc_bd0a2c102da4

Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent… — Europe PMC PMID:41096062

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41096062
DOI
10.3390/jcm14196984
License (as archived)
solo-consultazione
Archived
2026-11-09T14:46:12.970Z
SHA-256 of the archived text
5dbfebc7550ef92b56840a77306cefaab372dbe866c0f7d3a36a548b5914a3b5
Stable URL of this page
https://metraipolis.com/documento/dc_bd0a2c102da4

How to cite

Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent… — Europe PMC PMID:41096062 — Europe PMC (en), https://europepmc.org/article/MED/41096062 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd0a2c102da4 (Metraipolis archive dc_bd0a2c102da4, sha256 5dbfebc7550ef92b56840a77306cefaab372dbe866c0f7d3a36a548b5914a3b5)
BibTeX
@misc{dcbd0a2c102da4,
  title = {Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent… — Europe PMC PMID:41096062},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41096062},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd0a2c102da4; sha256 5dbfebc7550ef92b56840a77306cefaab372dbe866c0f7d3a36a548b5914a3b5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096062. Agents can read the archived copy with the MCP tool read_document.